Table 3.
Correlation analysis between monocyte and variables at the time of biologic discontinuation using Pearson correlation analysis.
| Crohn’s disease (N = 159) | Variables at biologic discontinuation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Monocyte | Duration of biologics treatment | Hematocrit | Albumin | ESR | CRP | Calprotectin | PCDAI | SES-CD | Time to relapse after D/C | |
| Percentage of WBC | Pearson coefficient | -0.022 | -0.145 | -0.326** | 0.299** | 0.314** | 0.371** | 0.088 | 0.318** | -0.283** |
| P-value | 0.781 | 0.069 | <0.001 | <0.001 | <0.001 | 0.005 | 0.272 | <0.001 | 0.001 | |
| Absolute count | Pearson coefficient | 0.003 | -0.119 | -0.344** | 0.339** | 0.379** | 0.385** | 0.168* | 0.422** | -0.107 |
| P-value | 0.973 | 0.134 | <0.001 | <0.001 | <0.001 | 0.003 | 0.034 | <0.001 | 0.236 | |
| Monocyte/PMN ratio | Pearson coefficient | -0.125 | -0.230** | -0.346** | 0.292** | 0.288** | 0.353** | 0.197* | 0.242** | -0.031 |
| P-value | 0.115 | 0.004 | <0.001 | <0.001 | <0.001 | 0.007 | 0.013 | 0.002 | 0.729 | |
| Ulcerative colitis (N = 29) | Variables at biologic discontinuation | |||||||||
| Monocyte | Duration of biologics treatment | Hematocrit | Albumin | ESR | CRP | Calprotectin | PUCAI | MES | Time to relapse after D/C | |
| Percentage of WBC | Pearson coefficient | 0.344 | 0.024 | 0.007 | 0.193 | 0.256 | -0.070 | -0.064 | -0.201 | -0.300 |
| P-value | 0.067 | 0.903 | 0.970 | 0.317 | 0.180 | 0.762 | 0.743 | 0.295 | 0.114 | |
| Absolute count | Pearson coefficient | -0.076 | 0.092 | -0.202 | 0.629** | 0.721** | 0.210 | 0.584** | 0.392* | 0.219 |
| P-value | 0.694 | 0.634 | 0.293 | <0.001 | <0.001 | 0.361 | 0.001 | 0.035 | 0.254 | |
| Monocyte/PMN ratio | Pearson coefficient | 0.316 | 0.353 | -0.111 | 0.329 | 0.648** | 0.050 | 0.259 | 0.148 | -0.066 |
| P-value | 0.095 | 0.060 | 0.565 | 0.082 | <0.001 | 0.829 | 0.175 | 0.444 | 0.734 | |
*P < 0.05, **P < 0.01 level (two-tailed).
Bold values mean statistically significant values with p-value <0.05.